Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · IEX Real-Time Price · USD
0.430
-0.010 (-2.21%)
At close: Jul 19, 2024, 4:00 PM
0.490
+0.060 (13.95%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $6.88 million as of July 22, 2024. Its market cap has decreased by -60.66% in one year.
Market Cap
6.88M
Enterprise Value
332.39K
1-Year Change
-60.66%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $6.88M, a decrease of -88.17%. That is a compound annual growth rate of -75.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 6.90M | -28.13% |
| Dec 29, 2023 | 9.60M | -83.50% |
| Jan 20, 2023 | 58.17M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XWELL | 7.40M |
| GlucoTrack | 7.23M |
| Pulmatrix | 7.12M |
| Virios Therapeutics | 6.98M |
| Notable Labs | 6.97M |
| Sunshine Biopharma | 6.88M |
| Alaunos Therapeutics | 6.76M |
| Tenax Therapeutics | 6.70M |